Robert E. Pollack
Corporate Officer/Principal chez The Trustees of Columbia University in The City of New York
Profil
Robert E.
Pollack is a Professor at The Trustees of Columbia University in The City of New York.
He was previously a Director at Tapestry Pharmaceuticals, Inc., NXXI, Inc., and Mirabilis Ventures, Inc.
Postes actifs de Robert E. Pollack
| Sociétés | Poste | Début |
|---|---|---|
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - |
Anciens postes connus de Robert E. Pollack
| Sociétés | Poste | Fin |
|---|---|---|
Mirabilis Ventures, Inc.
 Mirabilis Ventures, Inc. Investment ManagersFinance Mirabilis Ventures, Inc. is a private equity fund based in Orlando, Florida. | Directeur/Membre du Conseil | 28/05/2008 |
Tapestry Pharmaceuticals, Inc.
 Tapestry Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tapestry Pharmaceuticals, Inc. develops, manufactures, and markets an anti-cancer pharmaceutical called Paclitaxel. It focuses on the development of proprietary therapies for the treatment of cancer, new products and technologies may involve the examination of individual molecules and classes of compounds. The company was founded in 1991 and is headquartered in Ankeny, IA. | Directeur/Membre du Conseil | 05/02/2008 |
NXXI, Inc.
 NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | Directeur/Membre du Conseil | 07/04/2005 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Tapestry Pharmaceuticals, Inc.
Tapestry Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tapestry Pharmaceuticals, Inc. develops, manufactures, and markets an anti-cancer pharmaceutical called Paclitaxel. It focuses on the development of proprietary therapies for the treatment of cancer, new products and technologies may involve the examination of individual molecules and classes of compounds. The company was founded in 1991 and is headquartered in Ankeny, IA. | Health Technology |
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | Health Technology |
Mirabilis Ventures, Inc.
Mirabilis Ventures, Inc. Investment ManagersFinance Mirabilis Ventures, Inc. is a private equity fund based in Orlando, Florida. | Finance |
